Key Financial Data Of Reporting Company

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7547517

Concept As at
2023-06-30
2023-04-01 to
2023-06-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-06-30
As at
2022-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
18,150,000,000 JPY
72,984,000,000 JPY
18,197,000,000 JPY
Ordinary profit (loss)
3,488,000,000 JPY
8,727,000,000 JPY
4,332,000,000 JPY
Net assets
137,833,000,000 JPY
136,836,000,000 JPY
137,853,000,000 JPY
Total assets
167,151,000,000 JPY
166,328,000,000 JPY
165,101,000,000 JPY
Basic earnings (loss) per share
66.99
144.80
76.91
Diluted earnings per share
Equity-to-asset ratio
0.821 xbrli:pure
0.819 xbrli:pure
0.831 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.